- Home
- GRND vs AMPH Comparison
GRND vs AMPH Comparison
Compare GRND & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRND
- AMPH
- Stock Information
- Founded
- GRND 2009
- AMPH 1996
- Country
- GRND United States
- AMPH United States
- Employees
- GRND N/A
- AMPH N/A
- Industry
- GRND Computer Software: Prepackaged Software
- AMPH Biotechnology: Pharmaceutical Preparations
- Sector
- GRND Technology
- AMPH Health Care
- Exchange
- GRND Nasdaq
- AMPH Nasdaq
- Market Cap
- GRND 2.1B
- AMPH 2.5B
- IPO Year
- GRND N/A
- AMPH 2014
- Fundamental
- Price
- GRND $13.65
- AMPH $51.45
- Analyst Decision
- GRND Strong Buy
- AMPH Buy
- Analyst Count
- GRND 3
- AMPH 4
- Target Price
- GRND $15.33
- AMPH $63.00
- AVG Volume (30 Days)
- GRND 464.9K
- AMPH 268.7K
- Earning Date
- GRND 11-07-2024
- AMPH 11-06-2024
- Dividend Yield
- GRND N/A
- AMPH N/A
- EPS Growth
- GRND N/A
- AMPH 62.07
- EPS
- GRND N/A
- AMPH 3.15
- Revenue
- GRND $300,034,000.00
- AMPH $712,891,000.00
- Revenue This Year
- GRND $30.64
- AMPH $18.04
- Revenue Next Year
- GRND $21.70
- AMPH $4.41
- P/E Ratio
- GRND N/A
- AMPH $16.26
- Revenue Growth
- GRND 34.98
- AMPH 31.80
- 52 Week Low
- GRND $5.71
- AMPH $36.56
- 52 Week High
- GRND $13.90
- AMPH $65.92
- Technical
- Relative Strength Index (RSI)
- GRND 63.17
- AMPH 59.40
- Support Level
- GRND $13.06
- AMPH $49.38
- Resistance Level
- GRND $13.90
- AMPH $51.84
- Average True Range (ATR)
- GRND 0.42
- AMPH 1.25
- MACD
- GRND 0.06
- AMPH 0.10
- Stochastic Oscillator
- GRND 80.54
- AMPH 78.90
About GRND Grindr Inc.
Grindr Inc is a social networking app for gay, bi, trans, and queer people. It is a social network that brings together gay and bisexual men who want to meet other men close to them in a completely discreet and anonymous way, without having to give any personal information or having to fill out a profile with confidential information in order to register.
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.